198205-80-0

Basic information

• Product Name: (2'-TRIFLUOROMETHYLBIPHENYL-4-YL)-METHANOL
• Synonyms: AKOS BH-2058;[2'-(TRIFLUOROMETHYL)[1,1'-BIPHENYL]-4-YL]METHANOL;(2'-TRIFLUOROMETHYLBIPHENYL-4-YL)-METHANOL;4-(2-(Trifluoromethyl)phenyl)benzyl alcohol;[4-[2-(trifluoromethyl)phenyl]phenyl]methanol
• CAS NO: 198205-80-0
• Molecular Formula: C14H11F3O
• Molecular Weight: 252.23
• Mol File: 198205-80-0.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (2'-TRIFLUOROMETHYLBIPHENYL-4-YL)-METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: (2'-TRIFLUOROMETHYLBIPHENYL-4-YL)-METHANOL(198205-80-0)
• EPA Substance Registry System: (2'-TRIFLUOROMETHYLBIPHENYL-4-YL)-METHANOL(198205-80-0)

Safety Data

• Hazardous Substances Data: 198205-80-0(Hazardous Substances Data)

Usage

General Description

(2'-Trifluoromethylbiphenyl-4-yl)-methanol is a chemical compound consisting of a biphenyl molecule with a trifluoromethyl group attached to the 2' carbon and a hydroxymethyl group attached to the 4' carbon. (2'-TRIFLUOROMETHYLBIPHENYL-4-YL)-METHANOL is used in the field of pharmaceuticals and agrochemicals as a building block for the synthesis of various bioactive molecules. It is also utilized in the development of materials for applications such as liquid crystals and organic light-emitting diodes. The trifluoromethyl group imparts unique chemical and physical properties to the molecule, making it valuable in a wide range of applications. Additionally, the hydroxymethyl group adds reactivity and functionality to the compound, allowing for further modifications and derivatization. Overall, (2'-trifluoromethylbiphenyl-4-yl)-methanol is an important intermediate in the synthesis of various biologically active compounds and materials with unique properties.

Upstream product

• 198205-95-7 2'-(trifluoromethyl)biphenyl-4-carbaldehyde 

Relevant articles and documents

S1P RECEPTORS MODULATORS

The invention relates to novel compounds that have S1P receptor modulating activity and, preferably, apoptotic activity and/or anti proliferative activity against cancer cells and other cell types. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, cancer. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as cancer.